<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04246944</url>
  </required_header>
  <id_info>
    <org_study_id>PI2018_843_0041</org_study_id>
    <nct_id>NCT04246944</nct_id>
  </id_info>
  <brief_title>Induced Membrane Properties in Children and Adults</brief_title>
  <acronym>EMIH</acronym>
  <official_title>Induced Membrane Properties in Children and Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bone reconstruction in critical sized defect (CSD) remains a real challenge in orthopedic
      surgery in children and adults. The Masquelet technique is an innovative therapeutic
      technique, which offers a bone reconstruction in two steps, by the formation of an induced
      membrane (IM) around a polymethylmethacrylate (PMMA) spacer placed into the bone defect.
      After, PMMA removal, the cavity is filled with corticocancellous graft allowing bone healing.
      Up to date, all angiogenesis and osteogenic properties of IM remain unknown. The purpose of
      this study is to characterize angiogenesis and osteogenic properties of IM in children and
      adults.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">January 2030</completion_date>
  <primary_completion_date type="Anticipated">January 2030</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of the BMP2 concentration of the induced membrane by immunodetection</measure>
    <time_frame>one year (one year from day of surgery)</time_frame>
    <description>Measure of the osteogenic property of the induced membrane will be made after harvesting the induced membrane</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BMP2 concentration of the induced membrane implanted in adults measured by immunodetection</measure>
    <time_frame>one year (one year from day of surgery)</time_frame>
    <description>measurement of osteogenic property of the induced membrane in adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMP2 concentration of the induced membrane implanted in children measured by immunodetection</measure>
    <time_frame>one year (one year from day of surgery)</time_frame>
    <description>measurement of osteogenic property of the induced membrane in children</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Bone Loss</condition>
  <condition>Surgery</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>harvesting induced membrane</intervention_name>
    <description>The induced membrane will be harvested during the second step of the bone reconstruction.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients treated at CHU Amiens-Picardie for bone critical sized defect treated
             using the induced membrane reconstruction technique.

          -  patients from 9 months to 60 years old

        Exclusion Criteria:

          -  Patients managed by another reconstruction technique for critical sized defect

          -  Patients under guardianship, curators or deprived of liberty.

          -  Pregnant and nursing women.

          -  Patients who refused to participate in the study and to sign informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Months</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Céline Klein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Céline Klein, MD</last_name>
    <phone>(33)322087571</phone>
    <email>klein.celine@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Céline Klein, MD</last_name>
      <phone>(33)322087571</phone>
      <email>klein.celine@chu-emaine.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 17, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>January 28, 2020</last_update_submitted>
  <last_update_submitted_qc>January 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>induced membrane</keyword>
  <keyword>critical size defect</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

